AI Is Transforming Theranostics Workflows

The convergence of nanomedicine and artificial intelligence is fundamentally transforming cancer theranostics—the simultaneous diagnosis and treatment of disease—through the precise creation of multifunctional nanoparticles. Traditional cancer therapies remain hampered by imprecise drug delivery, systemic toxicity, and late-stage detection, challenges that AI-integrated nanoplatforms are now beginning to overcome. Key theranostic nanomaterials—including liposomes, gold nanoparticles, iron oxide